These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 1010710)
21. Diazepam-induced changes in tardive dyskinesia: suggestions for a new conceptual model. Singh MM; Becker RE; Pitman RK; Nasrallah HA; Lal H; Dufresne RL; Weber SS; McCalley-Whitters M Biol Psychiatry; 1982 Jun; 17(6):729-42. PubMed ID: 6125219 [TBL] [Abstract][Full Text] [Related]
22. Olanzapine for the treatment of tardive dyskinesia. Almeida OP J Clin Psychiatry; 1998 Jul; 59(7):380-1. PubMed ID: 9714267 [No Abstract] [Full Text] [Related]
23. Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole. Grant MJ; Baldessarini RJ Ann Pharmacother; 2005 Nov; 39(11):1953. PubMed ID: 16219895 [No Abstract] [Full Text] [Related]
24. Pisa syndrome: acute and tardive forms. Praharaj SK; Arora M South Med J; 2007 Aug; 100(8):853-4. PubMed ID: 17713320 [No Abstract] [Full Text] [Related]
25. Tardive dyskinesia in a nonpsychiatric patient due to short-term use of a neuroleptic/anticholinergic combination drug. Chouinard G; Boisvert D; Bradwejn J Can Med Assoc J; 1982 Apr; 126(7):821-2, 827. PubMed ID: 6122496 [No Abstract] [Full Text] [Related]
26. Tardive dyskinesia: are first signs reversible? Quitkin F; Rifkin A; Gochfeld L; Klein DF Am J Psychiatry; 1977 Jan; 134(1):84-7. PubMed ID: 12666 [TBL] [Abstract][Full Text] [Related]
27. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients. Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253 [TBL] [Abstract][Full Text] [Related]
28. Analysis of single, double-blind procedures, maintenance of placebo effects, and drug-induced dyskinesia with mentally retarded persons--a brief report [proceedings]. Breuning SE; Ferguson DG; Cullari S Psychopharmacol Bull; 1981 Jan; 17(1):122-3. PubMed ID: 7232641 [No Abstract] [Full Text] [Related]
30. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study. Bishnoi M; Chopra K; Kulkarni SK Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1130-8. PubMed ID: 17513028 [TBL] [Abstract][Full Text] [Related]
31. [Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms]. Lejoyeux M; Gorwood P; Stalla-Bourdillon A; Adès J Encephale; 1993; 19(1):17-21. PubMed ID: 8275889 [TBL] [Abstract][Full Text] [Related]